Kamal R. Mahtani

I noticed this on twitter from the Research to Publication eLearning programme at the BMJ. A really helpful resource for research and teaching:

(thanks BMJ)

 

• How to estimate the health benefits of additional research and changing clinical practice

Published

November 25, 2015

• Three simple rules to ensure reasonably credible subgroup analyses

Published

November 04, 2015

• STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies

Published

October 28, 2015

• How to develop a more accurate risk prediction model when there are few events

Published

August 11, 2015

• The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola

Published

July 27, 2015

 

• Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis

Published

June 09, 2015

 

• Cluster randomised trials with repeated cross sections: alternatives to parallel group designs

Published

June 08, 2015

 

• Statistics Notes: Bootstrap resampling methods

Published

June 02, 2015

• CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement

Published

May 14, 2015

• CONSORT extension for reporting N-of-1 trials (CENT) 2015: Explanation and elaboration

Published

May 14, 2015

• The PRECIS-2 tool: designing trials that are fit for purpose

Published

May 08, 2015

 

• Setting number of decimal places for reporting risk ratios: rule of four

Published

April 27, 2015

 

• Development of phenotype algorithms using electronic medical records and incorporating natural language processing

Published

April 24, 2015

 

• Anonymizing and sharing individual patient data

Published

March 20, 2015

• Process evaluation of complex interventions: Medical Research Council guidance

Published

March 19, 2015

• Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

Published

March 16, 2015

 

• Under-reporting and case fatality estimates for emerging epidemics

Published

March 16, 2015

• The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting

Published

February 06, 2015

• Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

Published

January 07, 2015

• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Published

January 02, 2015

 

• A guide to research partnerships for pragmatic clinical trials

Published

December 01, 2014

• Uncertainty and sampling error

Published

November 25, 2014

• Uncertainty beyond sampling error

Published

November 25, 2014

 

• A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

Published

September 24, 2014

• Regression discontinuity designs: an approach to the evaluation of treatment efficacy in primary care using observational data

Published

September 08, 2014

 

• Interpreting and comparing risks in the presence of competing events

Published

August 21, 2014

• Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data

Published

March 31, 2014

 

• Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide

Published

March 07, 2014

 

• Converting an odds ratio to a range of plausible relative risks for better communication of research findings

Published

January 24, 2014

 

• A multicomponent decision tool for prioritising the updating of systematic reviews

Published

December 13, 2013

 

• Dangers of non-specific composite outcome measures in clinical trials

Published

November 22, 2013

• Implementation research: what it is and how to do it

Published

November 20, 2013

 

• Cascade diagrams for depicting complex interventions in randomised trials

Published

November 15, 2013

• Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research

Published

November 11, 2013

 

• Value of composite reference standards in diagnostic research

Published

October 25, 2013

• How to access and process FDA drug approval packages for use in research

Published

October 14, 2013

 

• IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage

Published

June 18, 2013

• IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages

Published

June 18, 2013

• IDEAL framework for surgical innovation 1: the idea and development stages

Published

June 18, 2013

• Statistics Notes: Missing outcomes in randomised trials

Published

June 06, 2013

• Diagnostic accuracy studies: how to report and analyse inconclusive test results

Published

May 16, 2013

 

• Demystifying trial networks and network meta-analysis

Published

May 14, 2013

• The Ottawa Statement on the ethical design and conduct of cluster randomised trials: précis for researchers and research ethics committees

Published

May 09, 2013

• Clinicians are right not to like Cohen’s κ

Published

April 12, 2013

 

• Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

Published

March 25, 2013

 

• Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes

Published

February 05, 2013

 

• Prognosis research strategy (PROGRESS) 4: Stratified medicine research

Published

February 05, 2013

 

• Differential dropout and bias in randomised controlled trials

Published

January 21, 2013

1 response

 

• SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

Published

January 09, 2013

2 responses

 

• Uncertainties in baseline risk estimates and confidence in treatment effects

Published

November 14, 2012

• Use of Mendelian randomisation to assess potential benefit of clinical intervention

Published

November 06, 2012

2 responses

 

• When is a further clinical trial justified?

Published

September 13, 2012

• Consort 2010 statement: extension to cluster randomized trials

Published

September 04, 2012

1 response

 

• Sample size calculations: should the emperor’s clothes be off the peg or made to measure?

Published

August 23, 2012

7 responses

 

• Interpreting diagnostic accuracy studies for patient care

Published

July 02, 2012

3 responses

 

• Comparative effectiveness research in cancer screening programmes

Published

May 24, 2012

2 responses

 

• Assessing the value of diagnostic tests: a framework for designing and evaluating trials

Published

February 21, 2012

2 responses

 

• Clinical prediction rules

Published

January 16, 2012

9 responses

 

• Out of sight but not out of mind: how to search for unpublished clinical trial evidence

Published

January 03, 2012

ResearchImpact of document type on reporting quality of clinical drug trials

ResearchCompliance with mandatory reporting of clinical trial results on ClinicalTrials.gov

ResearchUnderstanding why evidence from randomised clinical trials may not be retrieved from Medline

ResearchAssessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data

ResearchEffect of reporting bias on meta-analyses of drug trials

ResearchPublication of NIH funded trials registered in ClinicalTrials.gov

EditorialMissing clinical trial data

• The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials

Published

October 18, 2011

2 responses

 

• Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice

Published

September 08, 2011

• Brackets (parentheses) in formulas

Published

August 11, 2011

5 responses

 

• How to obtain the confidence interval from a P value

Published

August 08, 2011

2 responses

 

• How to obtain the P value from a confidence interval

Published

August 08, 2011

• Verification problems in diagnostic accuracy studies: consequences and solutions

Published

August 02, 2011

• Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Published

July 22, 2011

1 response

 

• Interpreting and reporting clinical trials with results of borderline significance

Published

July 04, 2011

9 responses

 

• Comparisons within randomised groups can be very misleading

Published

May 06, 2011

• Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting

Published

April 11, 2011

• Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting

Published

April 07, 2011

• Strengthening the reporting of genetic risk prediction studies: the GRIPS statement

Published

March 16, 2011

• Correlation in restricted ranges of data

Published

March 11, 2011

1 response

 

• Interpretation of random effects meta-analyses

Published

February 10, 2011

3 responses

 

• Strategy for intention to treat analysis in randomised trials with missing outcome data

Published

February 07, 2011

• Strengths and weaknesses of hospital standardised mortality ratios

Published

January 21, 2011

2 responses

 

• Three techniques for integrating data in mixed methods studies

Published

September 17, 2010

• Assessing equity in systematic reviews: realising the recommendations of the Commission on Social Determinants of Health

Published

September 13, 2010

2 responses

 

• Evaluating policy and service interventions: framework to guide selection and interpretation of study end points

Published

August 27, 2010

1 response

 

• Importance of accurately identifying disease in studies using electronic health records

Published

August 19, 2010

• Taking healthcare interventions from trial to practice

Published

August 13, 2010

3 responses

 

• Random measurement error and regression dilution bias

Published

June 23, 2010

• An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials

Published

May 04, 2010

• Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses

Published

March 30, 2010

7 responses

 

• CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

Published

March 24, 2010

8 responses

 

• CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

Published

March 24, 2010

4 responses

 

• Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design

Published

March 19, 2010

3 responses

 

• Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

Published

March 12, 2010

1 response

 

• Economic impact of disease and injury: counting what matters

Published

March 02, 2010

• The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

Published

February 15, 2010

2 responses

 

• Meta-analysis of individual participant data: rationale, conduct, and reporting

Published

February 05, 2010

• Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers

Published

January 29, 2010

2 responses

 

• The routine use of patient reported outcome measures in healthcare settings

Published

January 18, 2010

2 responses

 

• Ten steps towards improving prognosis research

Published

December 31, 2009

3 responses

 

• Good publication practice for communicating company sponsored medical research: the GPP2 guidelines

Published

November 30, 2009

11 responses

 

• Use of multiperspective qualitative interviews to understand patients’ and carers’ beliefs, experiences, and needs

Published

October 14, 2009

• Bias in identifying and recruiting participants in cluster randomised trials: what can be done?

Published

October 09, 2009

• The tyranny of power: is there a better way to calculate sample size?

Published

October 06, 2009

5 responses

 

• Use of serial qualitative interviews to understand patients’ evolving experiences and needs

Published

September 28, 2009

1 response

 

• Critical reflections on the rise of qualitative research

Published

September 15, 2009

• The double jeopardy of clustered measurement and cluster randomisation

Published

August 21, 2009

• The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Published

July 21, 2009

1 response

 

• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Published

July 21, 2009

4 responses

 

• Assessing the severity of the novel influenza A/H1N1 pandemic

Published

July 14, 2009

4 responses

 

• Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

Published

June 29, 2009

• Prognosis and prognostic research: application and impact of prognostic models in clinical practice

Published

June 04, 2009

• Prognosis and prognostic research: validating a prognostic model

Published

May 28, 2009

• Prognosis and prognostic research: Developing a prognostic model

Published

March 31, 2009

• Prognosis and prognostic research: what, why, and how?

Published

February 23, 2009

1 response

 

• Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project

Published

January 19, 2009

• Evaluating service delivery interventions to enhance patient safety

Published

December 17, 2008

• Improving the reporting of pragmatic trials: an extension of the CONSORT statement

Published

November 11, 2008